Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lerer

Showing results (181-190 of 269) with videos related to

Pageof 27
Sort By:
Clinical Nuclear Medicine|January 22, 2004
Spontaneous retroperitoneal hemorrhage localized by blood pool scintigraphyDaniel B Lerer, Alla M Rozenblit, Jacob Cynamon, et al.
The Israel Journal of Psychiatry and Related Sciences|February 24, 2001
An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive declineS Schreiber, O Kampf-Sherf, M Gorfine, et al.
Psychoneuroendocrinology|January 1, 1981
Lack of effect of beta-2 adrenergic stimulation on human prolactinJ Bannet, B Lerer, R P Ebstein, et al.
Psychological Medicine|February 1, 1989
Distinct memory impairments following electroconvulsive therapy and imipramineA Calev, E Ben-Tzvi, B Shapira, et al.
European Journal of Pharmacology|May 7, 1982
Electroconvulsive shock prevents dopamine receptor supersensitivityB Lerer, K Jabotinsky-Rubin, J Bannet, et al.
Journal of Psychiatric Research|January 1, 1990
Cyclic AMP second messenger signal generation in EBV-transformed lymphoblastoid cells from schizophrenic patientsR P Ebstein, E R Bennett, J Hadjez, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1992
Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depressionB Shapira, B Lerer, S Kindler, et al.
Psychopharmacology|August 13, 1999
Low doses of ipsapirone increase growth hormone but not oxytocin secretion in normal male and female subjectsM E Newman, Q Li, Y Gelfin, et al.
The Pharmacogenomics Journal|September 14, 2006
Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphismA K Tiwari, S N Deshpande, B Lerer, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 16, 2006
Evaluation of association of SNPs in the TNF alpha gene region with schizophreniaB Morar, S G Schwab, M Albus, et al.
Pageof 27

Showing results (181-190 of 269) with videos related to

Sort By:
Pageof 27
Clinical Nuclear Medicine|January 22, 2004
Spontaneous retroperitoneal hemorrhage localized by blood pool scintigraphyDaniel B Lerer, Alla M Rozenblit, Jacob Cynamon, et al.
The Israel Journal of Psychiatry and Related Sciences|February 24, 2001
An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive declineS Schreiber, O Kampf-Sherf, M Gorfine, et al.
Psychoneuroendocrinology|January 1, 1981
Lack of effect of beta-2 adrenergic stimulation on human prolactinJ Bannet, B Lerer, R P Ebstein, et al.
Psychological Medicine|February 1, 1989
Distinct memory impairments following electroconvulsive therapy and imipramineA Calev, E Ben-Tzvi, B Shapira, et al.
European Journal of Pharmacology|May 7, 1982
Electroconvulsive shock prevents dopamine receptor supersensitivityB Lerer, K Jabotinsky-Rubin, J Bannet, et al.
Journal of Psychiatric Research|January 1, 1990
Cyclic AMP second messenger signal generation in EBV-transformed lymphoblastoid cells from schizophrenic patientsR P Ebstein, E R Bennett, J Hadjez, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1992
Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depressionB Shapira, B Lerer, S Kindler, et al.
Psychopharmacology|August 13, 1999
Low doses of ipsapirone increase growth hormone but not oxytocin secretion in normal male and female subjectsM E Newman, Q Li, Y Gelfin, et al.
The Pharmacogenomics Journal|September 14, 2006
Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphismA K Tiwari, S N Deshpande, B Lerer, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 16, 2006
Evaluation of association of SNPs in the TNF alpha gene region with schizophreniaB Morar, S G Schwab, M Albus, et al.
Pageof 27